Safety and Effectiveness of Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study

BACKGROUND: Major randomized trials assessing non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation generally excluded patients with hemoglobin <10 g/dL. This study evaluated the safety and effectiveness of NOACs in patients with atrial fibrillation and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Am Heart Assoc
Glavni autori: Wang, Chun‐Li, Wu, Victor Chien‐Chia, Huang, Yu‐Tung, Kuo, Chang‐Fu, Chu, Pao‐Hsien, Chen, Yu‐Ling, Wen, Ming‐Shien, Chang, Shang‐Hung
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512084/
https://ncbi.nlm.nih.gov/pubmed/31020896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.012029
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items